Skip to main content

Report 2021, Shingles Vaccine Market Size, Share, Growth, Trends, Competitive Analysis, Revenue, Forecast

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Shingles Vaccine Market Research Report Are Merck & Co. Inc., GlaxoSmithKline plc, SK Bioscience and other key market players.

Pune, India, Aug. 12, 2021 (GLOBE NEWSWIRE) — The global shingles vaccine market size is projected to experience dynamic growth in the forthcoming years owing to the rising number of ageing population across the world, finds Fortune Business Insights™ in its report, titled “Shingles Vaccine Market, 2021-2028”.

Shingles is a disease caused due to the virus known as varicella-zoster. Shingles is a reactivation of the chickenpox in the human body, which can cause a painful rash. There has been a rising prevalence of shingles among the adults and ageing population around the world owing to the re-occurrence of varicella-zoster virus in the human body. Thus, this is an important factor responsible for the growth of this market. For instance, as per the report published by the Centre for Disease Control and Prevention, approximately 1 million people in the US are suffering from shingles every year, which is projected to drive the growth of this market.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/shingles-vaccine-market-102072

However, the lack of awareness about shingles in the developing nations is projected to restrict the growth of this market. In spite of the COVID-19 pandemic and the imposing of lockdown restrictions worldwide, the production and distribution of shingles vaccine has not been impacted due to the increasing government efforts for the prevention of shingles in the form of arranging free vaccination programs on a regular basis. Thus, the COVID-19 pandemic has not impacted the shingles vaccine market, which is one of the driving factors for the growth of this market.

Industry Development:

June 2019: GSK received approval from the Chinese regulatory authorities for the marketing of the shingrix for adults aged over fifty years and above.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/shingles-vaccine-market-102072


Rising Awareness about Shingles Worldwide to Fuel the Market

There has been an increasing awareness by the government regarding shingles especially in the developing nations as most of the people in the developing countries are unaware about the adverse side effects of shingles and its proper treatment. Hence, the governments of these countries have increased their investments towards the prevention of shingles across several regions. This is a crucial factor responsible for the growth of this market.

Rising Demand for Shingles Vaccine to Boost the North America Market Growth

North America region is projected to witness substantial growth in the shingles vaccine market share on account of the rising demand for shingles vaccine and the increasing prevalence of shingles in this region.

Europe is anticipated to grow speedily in this market due to the easy accessibility of vaccines and appropriate government policies in this region. Asia Pacific region is projected to grow rapidly in this market owing to the rising government initiatives towards the prevention of shingles in the countries such as India, China, Australia, and others.


Quick Buy –  Shingles Vaccine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102072  


Market Segmentation:

On the basis of drug, this market is divided into zostavax, shingrix, and others. By distribution channel, the market is classified into hospital pharmacy and retail pharmacy. Based on geography, the market is clubbed into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Highlights/Summary:

The report provides an exhaustive assessment of each market segment and also offers an in-depth analysis of the market drivers, trends, opportunities, and hindrances. Furthermore, the report contains a granular examination of the regional developments impacting the market, along with a thorough evaluation of the top market players and their key strategies.


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/customization/shingles-vaccine-market-102072


Increasing Production and Distribution of Shingles Vaccines to Feed Competition

The leading companies in the shingles vaccine market are focusing on the increasing production and distribution of shingles vaccines owing to the high demand for such vaccines especially in the developing countries. This has resulted in the increasing competition among key companies which will help them to diversify their business portfolio and strengthen their market position.

List of Key Players Covered in the Shingles Vaccine Market Report:

  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • SK Bioscience

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/queries/shingles-vaccine-market-102072


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.